Free Trial
NYSEMKT:IBIO

iBio (IBIO) Stock Price, News & Analysis

iBio logo
$0.76 +0.03 (+3.41%)
As of 07/23/2025

About iBio Stock (NYSEMKT:IBIO)

Key Stats

Today's Range
$0.74
$0.78
50-Day Range
$0.71
$1.03
52-Week Range
N/A
Volume
683,388 shs
Average Volume
113,212 shs
Market Capitalization
$12.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iBio and its competitors with MarketBeat's FREE daily newsletter.

IBIO Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Pharos iBio Co. Ltd.
iBio files to sell 246K shares of common stock for holders
iBio Announces New Investments from Board Members and Officers
See More Headlines

IBIO Stock Analysis - Frequently Asked Questions

iBio's stock was trading at $2.45 at the beginning of the year. Since then, IBIO shares have decreased by 69.0% and is now trading at $0.7607.

iBio, Inc. (NYSEMKT:IBIO) announced its quarterly earnings results on Monday, November, 15th. The company reported ($20.00) EPS for the quarter, topping analysts' consensus estimates of ($25.00) by $5.00. The company had revenue of $0.21 million for the quarter.

Shares of iBio reverse split on the morning of Wednesday, November 29th 2023.The 1-20 reverse split was announced on Wednesday, November 29th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of IBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iBio investors own include Inovio Pharmaceuticals (INO), NIO (NIO), Vaxart (VXRT), Plug Power (PLUG), Tesla (TSLA), Advanced Micro Devices (AMD) and Ford Motor (F).

Company Calendar

Last Earnings
11/15/2021
Today
7/24/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSEMKT
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEMKT:IBIO
CIK
1420720
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.01 million
Net Margins
N/A
Pretax Margin
-41,546.00%
Return on Equity
-150.59%
Return on Assets
-52.83%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
0.91
Quick Ratio
0.91

Sales & Book Value

Annual Sales
$375 thousand
Price / Sales
33.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.64 per share
Price / Book
0.29

Miscellaneous

Outstanding Shares
16,519,000
Free Float
3,445,000
Market Cap
$12.57 million
Optionable
N/A
Beta
0.94
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSEMKT:IBIO) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners